Left Main Coronary Intervention Research Articles

Challenges of Endovascular Treatment in Patients With “False” Left Main Coronary Bifurcation Lesions

We discuss main challenges of much-debated endovascular treatment in patients with “false” bifurcation stenoses of the left main coronary artery. There are no convincing literature data on the rationale of planning complete bifurcation stenting using 2 stents and clear indications for this procedure. We highlight the importance of studying the effectiveness and safety of the complex routine use of various intravascular imaging during the left main coronary artery percutaneous coronary intervention. We analyzed observations in which a “false” bifurcation lesion can only be considered an ostial stenosis, which will affect the stenting strategy. We focus on the development of universal algorithms for performing endovascular interventions, including those using intravascular imaging which role at each stage of surgery should be additionally studied.

A 10-year Review of Left Main (LM) Coronary Artery Percutaneous Coronary Intervention (PCI) in South Western Sydney Local Health District (SWSLHD)

A 10-year Review of Left Main (LM) Coronary Artery Percutaneous Coronary Intervention (PCI) in South Western Sydney Local Health District (SWSLHD)

Sex disparity of DAPT noncompliance in patients with left main stem PCI with DES

This retrospective study aims to explore the sex disparity in dual antiplatelet therapy (DAPT) noncompliance among left main stem percutaneous coronary intervention (PCI) patients with drug-eluting stent (DES) and identify predictors associated with non-adherence. Data were collected from the medical records of 1585 patients, including 1104 males and 481 females, who underwent left main stem PCI with DES. Baseline characteristics, angiographic features, and DAPT compliance rates at 1 month and 12 months were analyzed. Univariate logistic regression was used to identify predictors of DAPT noncompliance. The overall DAPT noncompliance rate at 1 month was 8.5%, increasing to 15.5% at 12 months. Females exhibited slightly higher noncompliance rates than males at both 1 month (15.6% vs 14.5%) and 12 months (28.1% vs 19.0%), although the difference was not statistically significant. Smoking status showed a modest impact on non-adherence, with current smokers exhibiting a lower noncompliance rate (14.9% at 1 month). Prior coronary artery disease history was associated with increased noncompliance at 12 months (18.9%). Angiographic characteristics, including lesion location and Syntax score, had no consistent association with DAPT noncompliance. This study highlights sex disparity in DAPT noncompliance among patients undergoing left main stem PCI with DES. Comorbidities, socioeconomic status, smoking status, and prior coronary artery disease history were identified as predictors of non-adherence.

C-48 | Real World Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention

C-48 | Real World Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention

A New Scoring System Predicting Side-Branch Occlusion in Patients Undergoing Left Main Bifurcation Intervention: The LM V-RESOLVE Score

BackgroundThe risk of side-branch (SB) occlusion is pivotal for decision making of stenting strategies during unprotected left main (LM) bifurcation percutaneous coronary intervention (PCI). Accordingly, this study aimed to develop a scoring system for predicting SB occlusion during unprotected LM bifurcation PCI. MethodsA total of 855 consecutive patients undergoing unprotected LM bifurcation PCI with provisional strategy at Fuwai Hospital from January 2014 to December 2016 were recruited. A prediction model was selected by means of all-subsets logistic regression, and a multivariable risk score (Left Main Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [LM V-RESOLVE]) was then established with incremental weights attributed to each component variable based on its estimate coefficients. SB occlusion was defined as any decrease in Thrombolysis in Myocardial Infarction (TIMI) flow grade or absence of flow in SB after main vessel (MV) stenting. ResultsSB occlusion occurred in 19 LM bifurcation lesions (2.22%). In multivariable model, 3 variables, including MV/SB diameter ratio, MV plaque ipsilateral to SB, and baseline diameter stenosis of SB, were independent predictors for SB occlusion (model C-statistic 0.829, 95% confidence interval [CI] 0.735-0.923, with good calibration). The risk score had a C-statistics of 0.830 (95% CI 0.738-0.923) with good calibration. Satisfactory discriminative ability of the risk score was also preserved in external validation (C-statistic 0.794, 95% CI 0.691-0.896). ConclusionsThe LM bifurcation–specific novel scoring system, LM V-RESOLVE, based on 3 simple baseline angiographic findings, could help to rapidly discriminate lesions at risk of SB occlusion during LM bifurcation PCI.

Expanded Single-Center Study: Combined Outcomes of Initial and Additional Cohorts in Left Main Coronary Artery Percutaneous Coronary Intervention

Background: Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Percutaneous coronary intervention (PCI), particularly on the left main coronary artery (LMCA), has emerged as a significant treatment option. Understanding the long-term outcomes of such interventions is crucial for optimizing patient care and guiding clinical decisions. Objective: To evaluate the three-year clinical outcomes of PCI procedures performed specifically on the LMCA. Methods: This study, conducted at the Peshawar Institute of Cardiology from April to September 2023, received ethical committee approval. Participants were identified through a review of medical records for individuals who underwent LMCA PCI. Data were collected via a pre-designed questionnaire and analyzed using SPSS version 26. Results: The study included 75 patients, with an average age of 61.49±10.41 years, comprising 57 males (76.0%) and 18 females (24.0%). During the hospital stay, complications included thrombectomy in 1 patient (1.3%), 2 deaths (2.7%), 1 case of bleeding (1.3%), and 1 cardiac arrest successfully reverted (1.3%). Post-discharge, 2 additional deaths (2.7%) occurred within one month, and 1 patient (1.3%) experienced angina after three months. The three-year follow-up revealed a mortality rate of 6 patients (8.0%). Conclusion: The study concludes that complications following LMCA PCI were relatively infrequent. However, it emphasizes the need for continued research to further elucidate the long-term outcomes of this procedure.

Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions

BackgroundIntravascular lithotripsy (IVL) safely and effectively modifies calcified coronary lesions during percutaneous coronary interventions (PCI). Data regarding its utility in modifying calcified left main coronary artery (LMCA) disease are limited. This study aimed to evaluate short-term outcomes of IVL-assisted LMCA PCI. MethodsThis retrospective multicenter all-comers study analyzed patients who underwent intravascular imaging-guided, IVL-assisted PCI for calcified LMCA disease. Clinical and procedural characteristics were obtained, including intravascular imaging measurements. Technical success was defined as successful stent deployment with <30% residual diameter stenosis. Major adverse cardiac events (MACE) was a composite of all-cause death, myocardial infarction, and target vessel revascularization evaluated immediately postprocedure and at 30-day follow-up. ResultsAmong 184 patients treated at 7 centers from 2019-2023, IVL-assisted LMCA PCI achieved 99.4% technical success. Calcium fracture was identified in 136/165 cases (82.4%) on post-IVL imaging. Pretreatment minimal luminal area increased significantly compared to post-PCI minimal stent area (MSA) (4.1 ± 1.3 to 9.3 ± 2.5 mm2, respectively; P < .001). There was a direct correlation between IVL balloon size and the final MSA (P = .002). In-hospital MACE was 4.4% and 30-day MACE was 8.8%. In multivariate logistic regression, presentation with troponin-positive myocardial infarction was the sole predictor of 30-day MACE. ConclusionsIVL-assisted PCI for calcified LMCA lesions was safe and resulted in high technical success rates, confirming its utility as an effective treatment in this challenging lesion subset.

Predictors of periprocedural myocardial infarction after left main bifurcation percutaneous coronary intervention guided by optical coherence tomography imaging: the PREVENT study

Abstract Background PMI is one of the most common and relevant complications that occur after PCI, but it is still a matter of controversy. This clinical entity has been frequently correlated to peculiar plaque morphological features by several intravascular imaging studies. PCI of the LM coronary artery is a complex procedural setting, where the prognostic value of PMI is higher. Intravascular ultrasound (IVUS) has a traditional predominance in the guidance of LM-PCI, but optical coherence tomography (OCT) outperforms IVUS in spatial resolution and has affirmed itself as a strong support to PCI. Purpose The aim of this study is to identify preprocedural and postprocedural optical coherence tomography (OCT) findings potentially related to periprocedural myocardial infarction (PMI) in patients undergoing percutaneous coronary intervention (PCI) for non-ostial left main (LM) bifurcation disease. Methods We retrospectively analyzed 76 patients who underwent OCT before and after LM-PCI. Definitions of OCT findings were derived from expert consensus documents and major OCT studies. PMI was defined in accordance with the Academic Research Consortium-2 (ARC-2) definition. Results The presence of TCFA was found to be an independent predictor of PMI, and coherently a significantly higher lipid core arc was observed in the PMI group. Mean stent area was the only post-PCI feature to result significantly higher in the PMI group. Conclusions We found the presence of TCFA at pre-PCI OCT was an independent predictor of PMI. A higher mean stent area at post-PCI OCT in patients who developed PMI may suggest that aggressive stent expansion could not always be the right choice in such a context.

TCT-155 Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Imaging-Guided Calcified Left Main Coronary Artery Percutaneous Coronary Interventions

TCT-155 Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Imaging-Guided Calcified Left Main Coronary Artery Percutaneous Coronary Interventions

Outcomes Prediction in Complex High-Risk Indicated Percutaneous Coronary Interventions in the Older Patients

Complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) is a poorly defined concept, which has not been validated in an older population before. This study aimed to evaluate the predictive value of the CHIP-PCI score in a large cohort of elderly patients and to identify potential further risk factors. This is a pooled analysis of 3 registries that included patients aged ≥75years who underwent percutaneous coronary intervention from 2012 to 2019: the multicenter prospective EPIC05-Sierra 75 study, the multicenter retrospective PACO-PCI (EPIC-15) registry, and the single-center, prospective Elderly-HCD registry. A total of 2,725 patients with a mean age of 81 ± 4years were included in the study; 269 patients (10%) met the primary end point of 1-year major adverse cardiac and cerebrovascular events (MACCEs), and 51 patients (2%) had in-hospital MACCEs. Of the 12 investigated original CHIP-PCI score variables, 5 were independent predictors: previous myocardial infarction, left ventricular ejection fraction <30%, chronic kidney disease, left main coronary artery percutaneous coronary intervention, and nonradial access. Furthermore, diabetes mellitus, anemia, and severe calcification showed to be significant predictors of MACCEs. The additional variables improved the discriminatory value of the CHIP-PCI score for 1-year MACCEs (modified CHIP-PCI score: area under the curve [AUC] 0.647 vs original CHIP-PCI score: AUC 0.598, p=0.02) and in-hospital MACCEs (AUC 0.729 vs 0.657, p=0.003, respectively). In conclusion, the CHIP-PCI score retains its prognostic value in older patients for in-hospital MACCEs; however, it is of limited value at 1-year follow-up. The modified CHIP-PCI score, including the 5 patient-related and 3 procedure-related factors, significantly improved its discriminatory potential.

Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.

The present study sought to determine the rate and prognostic implications of post-procedural physiologically significant residual ischemia according to Murray law-based quantitative flow ratio (μQFR) after left main (LM) bifurcation percutaneous coronary intervention (PCI). Consecutive patients undergoing LM bifurcation stenting at a large tertiary care center between January 2014 and December 2016 with available post-PCI μQFR were included. Physiologically significant residual ischemia was defined by post-PCI μQFR values ≤0.80 in the left anterior descending (LAD) or left circumflex artery (LCX). The primary outcome was 3-year cardiovascular death. The major secondary outcome was 3-year bifurcation-oriented composite endpoint (BOCE). Among 1170 included patients with analyzable post-PCI μQFR, 155 (13.2%) had residual ischemia in either LAD or LCX. Patients with vs. those without residual ischemia had a higher risk of 3-year cardiovascular mortality [5.4% vs. 1.3%; adjusted hazard ratio (HR) 3.20, 95% confidence interval (CI): 1.16-8.80]. The 3-year risk of BOCE was significantly higher in the residual ischemia group (17.8% vs. 5.8%; adjusted HR 2.79, 95% CI: 1.68-4.64), driven by higher incidence of the composite of cardiovascular death and target bifurcation-related myocardial infarction (14.0% vs. 3.3%; adjusted HR 4.06, 95% CI: 2.22-7.42). A significant, inverse association was observed between continuous post-PCI μQFR and the risk of clinical outcomes (per 0.1 μQFR decrease, HR of cardiovascular death 1.27, 95% CI: 1.00-1.62; HR of BOCE 1.29, 95% CI: 1.14-1.47). After angiographically successful LM bifurcation PCI, residual ischemia assessed by μQFR was identified in 13.2% of patients and was associated with higher risk of 3-year cardiovascular death, indicating the superior prognostic value of post-PCI physiological assessment.

TCTAP C-093 Complex Calcified Left Main and LAD Percutaneous Coronary Intervention After CABG

TCTAP C-093 Complex Calcified Left Main and LAD Percutaneous Coronary Intervention After CABG

Short term Outcomes of left main coronary artery Percutaneous Coronary Intervention A large tertiary care dedicated Cardiac Centre experience.

Background: Left main coronary artery intervention is getting common throughout the world. Data in our local population are still lacking. Our aim was to study the short-term outcomes after revascularization of left main coronary artery (LMCA) at a tertiary care Centre at public sector hospital in Pakistan.&#x0D; Methodology: In this descriptive study conducted at Peshawar Institute of Cardiology, we enrolled consecutive patients who underwent LMCA intervention from January 2021 till November 2021. Direct patients’ interviews, reviewing charts and records were used for in-hospital outcomes and telephonic and physical follow up were used to document three months outcome. Results were expressed as means, standard deviations and percentages for different variables.&#x0D; Results: Total number of patients in the study were 68. The mean age was 61 ± 11.7 years, 73.5% (50 cases) were males. Six patients (8.8%) were in cardiogenic shock and five of them were put on mechanical ventilation. Thirty-two (47.1%) patients had presentation as acute coronary syndrome (ACS) within the last seven days. Mean follow up time was 170 ± 71 days. Mortality in-hospital was 5.8%, at the mean follow up it was 8.8%.&#x0D; Conclusion: Comparable short-term outcomes of left main coronary artery PCI, to national and international data can be achieved in a public sector hospital in our country where resources are scarce. Hence LMCA PCI is an acceptable alternative to CABG in suitable patients.

Contemporary left main coronary artery percutaneous intervention in a single cardiac centre

Percutaneous coronary intervention (PCI) to left main coronary artery (LMCA) is an alternative to coronary artery bypass grafting (CABG) in selected patients. Contemporary patterns of practice and outcomes in LMCA PCI in Malaysia are not well studied.

Intracoronary Imaging in left main stent percutaneous coronary intervention has a clear survival benefit particularly in more complex patients

Abstract Background Left Main Stem Disease (LMS) is prognostically important coronary artery disease that is managed either with coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI). Use of intracoronary imaging (ICI) modalities such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have been shown to improve outcomes with PCI revascularization. The primary objective of this study was to evaluate the impact of ICI on outcomes following LMS PCI. Methods Retrospective observation study of 498 (5.1% of all PCI cases) patients who had undergone LMS PCI at our tertiary primary PCI centre hospital over a 11-year period between July 2010-July 2021. Data was collected from electronic medical records. Follow-up was also obtained through linkage with the Office of National Statistics. Results The mean age at the time of enrolment was 70.7±11.5 years. Majority of the patients were male 351 (70.5%). 353 (70.9%) of cases had acute coronary syndrome (ACS) presentation while the remainder were elective procedures. Mean follow-up duration was 3.75±3.06 years. Survival calculated by Kaplan-Meier was 70%. 87 patients (17.5%) deceased during first year of enrolment. 344 (69.1%) patients had ICI, with IVUS in 316 (63.5%) and OCT in 28 (5.6%) patients. IVUS comprised 91.9% of ICI procedures. Protected LMS (OR 0.175, 95% CI: 0.037–0.833, P-value=0.029) and the use of left ventricular mechanical support device (OR 0.324, 95% CI: 0.122–0.859, P-value=0.024) were associated with decreased odds of undergoing an ICI. Patients undergoing ICI had significantly better survival compared to those without ICI (HR: 0.54, P&amp;lt;0.001). Moreover, OCT showed significantly better survival compared with IVUS (HR: 0.181, P=0.017). Use of ICI was associated with better survival in patients who had Rotablation (HR: 0.455, 95% CI: 0.232–0.892, P=0.022), ACS (HR: 0.523, 95% CI: 0.383–0.714, P&amp;lt;0.001) or comorbidities of diabetes and stroke (HR: 0.551, 95% CI: 0.337–0.807, P=0.002). Conclusion ICI in LMS PCI has a significant survival benefit in our dataset. This is especially the case in patients presenting with ACS, those with comorbidities of Diabetes mellitus and stroke and those undergoing rotablation. Funding Acknowledgement Type of funding sources: None.

Left Main Stem Percutaneous Coronary Intervention: Does On-Site Surgical Cover Make a Difference?

Nonsurgical centers (NSC) contribute significantly to the capacity of overall percutaneous coronary intervention (PCI) in the United Kingdom. Although previous studies have demonstrated similar PCI outcomes in surgical centers (SC) versus NSC, it is unknown whether this applies to more complex procedures such as left main stem (LMS) PCI. We compared patient characteristics and outcomes of LMS PCI performed across SC and NSC in England and Wales. A retrospective analysis of procedures between January 2006 and March 2020 was performed using the British Cardiovascular Intervention Society database and stratified according to the surgical status of the center. The primary outcomes assessed were in-hospital major adverse cardiovascular and cerebrovascular events, all-cause mortality, and Bleeding Academic Research Consortium stage 3 to 5 bleeding. Forty thousand seven hundred forty-four patients underwent LMS PCI during the period, of which 13 922 (34.2%) had their procedure performed at an NSC. The proportion of LMS PCI performed in NSC increased >2-fold (15.9% in 2006 to 36.7% in 2020). There was no association between surgical cover location and in-hospital mortality (odds ratio, 0.92 [95% CI, 0.69-1.22]), in-hospital major adverse cardiovascular and cerebrovascular events (odds ratio, 1.00 [95% CI, 0.79-1.25]), or emergency coronary artery bypass graft surgery (odds ratio, 1.00 [95% CI, 0.95-1.06]). NSC had lower Bleeding Academic Research Consortium 3 to 5 bleeding complications (odds ratio, 0.53 [95% CI, 0.34-0.82]). There has been an increase in LMS PCI volumes at NSC, particularly elective LMS PCI. LMS PCI performed at NSC was not associated with increased mortality, in-hospital major adverse cardiovascular and cerebrovascular events, or emergency coronary artery bypass graft surgery, despite higher disease complexity.

Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.

Left main stem percutaneous coronary intervention (LMS-PCI) is a complex high-risk procedure which can be performed as an alternative to coronary artery bypass graft (CABG) procedure in surgical turn-down patients or where there is equipoise in percutaneous versus surgical strategies. Current guidelines suggest that PCI is an appropriate alternative to CABG in patients with unprotected LMS disease and low SYNTAX score. However, "real world"data on outcomes of LMS-PCI remain limited. This study aims to quantify and determine predictors of mortality following LMS-PCI. Using local coronary angioplasty registries from two UK centers, all LMS-PCI cases were identified from 2016 to 2020. Descriptive statistics and multivariate logistic regressions were used to examine the association between baseline and procedural characteristics with 30-day and 12-month mortality. We identified 484 cases of LMS-PCI between 2016 and 2020. There was a year-on-year increase in the number of LMS-PCI, the highest being in 2020. Covariates associated with higher 30-day mortality were age (OR 1.07, 95% CI: 1.02-1.12) and shock preprocedure (OR 23.88, 95% CI: 7.90-72.20). Covariates associated with higher 12-month mortality were age (OR 1.04, 95% CI: 1.01-1.08), acute coronary syndrome (ACS)(OR 2.50, 95% CI: 1.08-5.80), renal disease (OR 5.24, 95% CI: 1.47-18.68), and shock preprocedure (OR 7.93, 95% CI: 3.30-19.05). Overall, 30-day and 12-month mortality in this contemporary data set were 9.5% and 16.7%, respectively, with significantly lower rates in elective cases (p < 0.01). Older age and cardiogenic shock preprocedure were associated with increased 30-day mortality after LMS-PCI.Twelve-month mortality was associated with older age, ACS presentation, preexistingrenal disease, and cardiogenic shock preprocedure.

TCT-276 Survival Benefit With Use of Intracoronary Imaging in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention

TCT-276 Survival Benefit With Use of Intracoronary Imaging in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention

TCT-146 Left Main Stem Percutaneous Coronary Intervention: Does Onsite Surgical Cover Make a Difference?

TCT-146 Left Main Stem Percutaneous Coronary Intervention: Does Onsite Surgical Cover Make a Difference?

How to deal with vessel diameter mismatch in left main bifurcation stenting.

Left main coronary artery percutaneous coronary intervention is particularly complex when stenting across the distal bifurcation is required in the presence of a diameter mismatch between the proximal main and distal branches. A suboptimal procedural result increases the risk of thrombosis and restenosis. Considering the paucity of data published on this topic, our objective was to provide technical solutions to deal with this complex anatomy. We described four cases showing the use of devices and techniques which allowed us to overcome a diameter discrepancy between adjacent coronary segments: (1) self-expanding nitinol stent; (2) stent platform with noteworthy expansion capacity; (3) the 'extended skirt' technique; (4) the 'trouser-leg' technique. In conclusion, the use of specific strategies and devices allows a safe and effective approach to be used to perform treatment that respects the coronary anatomy, and to optimize percutaneous coronary intervention results in complex scenarios.